Breaking News Instant updates and real-time market news.

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12

Cellular Biomedicine downgraded to Neutral at Baird

As reported previously, Baird analyst Madhu Kumar downgraded Cellular Biomedicine to Neutral from Outperform on the offer to take the company private at $19.50 per shares. Kumar lowered his price target to $19 from $26 on Celluar Biomedicine shares.

CBMG Cellular Biomedicine
$17.86

0.11 (0.62%)

09/17/19
BTIG
09/17/19
INITIATION
BTIG
Buy
Cellular Biomedicine initiated with a Buy at BTIG
09/17/19
BTIG
09/17/19
INITIATION
Target $19
BTIG
Buy
Cellular Biomedicine initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Cellular Biomedicine (CBMG) with a Buy rating and a price target of $19. The analyst cites the company's growth of manufacturing space to 100K sqf across its four China facilities, also noting its key partnerships with GE Healthcare (GE) and Thermo Fisher (TMO). Murphy adds that these relationships have allowed Cellular Biomedicine to develop "integrated, semi-automated, and closed processes" in manufacturing of raw materials and high-throughput commercial manufacturing scale, which lowers its goods-sold cost while maintaining the relative quality of its products.
09/17/19
09/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Match Group (MTCH) initiated with a Buy at Citi. 2. Restaurant Brands (QSR) initiated with a Buy at Argus. 3. Orchard Therapeutics (ORTX) initiated with a Buy at Guggenheim. 4. Axonics (AXNX) initiated with an Outperform at SVB Leerink. 5. Cellular Biomedicine (CBMG) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/19
BARD
11/12/19
DOWNGRADE
Target $19
BARD
Neutral
Cellular Biomedicine downgraded to Neutral from Outperform at Baird
Baird analyst Madhu Kumar downgraded Cellular Biomedicine to Neutral from Outperform with a $19 price target.

TODAY'S FREE FLY STORIES

EW

Edwards Lifesciences

$238.97

-3.9 (-1.61%)

05:18
12/09/19
12/09
05:18
12/09/19
05:18
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.05

-0.04 (-0.09%)

, THOR

Synthorx

$24.98

-0.02 (-0.08%)

05:16
12/09/19
12/09
05:16
12/09/19
05:16
Hot Stocks
Sanofi to acquire Synthorx for $68 per share in cash »

Sanofi (SNY) and Synthorx…

SNY

Sanofi

$46.05

-0.04 (-0.09%)

THOR

Synthorx

$24.98

-0.02 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

CHK

Chesapeake

05:15
12/09/19
12/09
05:15
12/09/19
05:15
Recommendations
Chesapeake analyst commentary  »

Chesapeake price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.76

0.0421 (5.86%)

05:15
12/09/19
12/09
05:15
12/09/19
05:15
Recommendations
Chesapeake analyst commentary  »

Chesapeake price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

$11.57

0.02 (0.17%)

05:12
12/09/19
12/09
05:12
12/09/19
05:12
Downgrade
Green Brick rating change  »

Green Brick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVR

NVR

$3,777.50

-83.65 (-2.17%)

05:12
12/09/19
12/09
05:12
12/09/19
05:12
Upgrade
NVR rating change  »

NVR upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEGEF

MEG Energy

$0.00

(0.00%)

05:11
12/09/19
12/09
05:11
12/09/19
05:11
Upgrade
MEG Energy rating change  »

MEG Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

05:10
12/09/19
12/09
05:10
12/09/19
05:10
Downgrade
Marathon Petroleum rating change  »

Marathon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DK

Delek US

$34.30

0.99 (2.97%)

05:10
12/09/19
12/09
05:10
12/09/19
05:10
Downgrade
Delek US rating change  »

Delek US downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$4.60

0.29 (6.73%)

05:10
12/09/19
12/09
05:10
12/09/19
05:10
Hot Stocks
ObsEva says PRIMROSE 2 Phase 3 trial met primary, secondary efficacy endpoints »

ObsEva reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$17.36

0.24 (1.40%)

05:09
12/09/19
12/09
05:09
12/09/19
05:09
Initiation
Plains GP Holdings initiated  »

Plains GP Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PAA

Plains All American

$17.30

0.29 (1.70%)

05:08
12/09/19
12/09
05:08
12/09/19
05:08
Initiation
Plains All American initiated  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

MAKSY

Marks & Spencer

$0.00

(0.00%)

05:06
12/09/19
12/09
05:06
12/09/19
05:06
Upgrade
Marks & Spencer rating change  »

Marks & Spencer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WING

Wingstop

$80.22

0.09 (0.11%)

05:04
12/09/19
12/09
05:04
12/09/19
05:04
Upgrade
Wingstop rating change  »

Wingstop upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$15.15

0.04 (0.26%)

05:00
12/09/19
12/09
05:00
12/09/19
05:00
Downgrade
Macy's downgraded to Sell from Neutral at Goldman Sachs »

Goldman Sachs analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORLY

O'Reilly Automotive

$445.56

4.52 (1.02%)

, LOW

Lowe's

$116.25

0.67 (0.58%)

04:57
12/09/19
12/09
04:57
12/09/19
04:57
Downgrade
O'Reilly Automotive, Lowe's, Dick's Sporting, BJ's Wholesale rating change  »

O'Reilly Automotive…

ORLY

O'Reilly Automotive

$445.56

4.52 (1.02%)

LOW

Lowe's

$116.25

0.67 (0.58%)

DKS

Dick's Sporting

$46.21

0.325 (0.71%)

BJ

BJ's Wholesale

$23.54

0.095 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

04:55
12/09/19
12/09
04:55
12/09/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

CHMA

Chiasma

$5.27

-0.04 (-0.75%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
Roth Capital biotech analyst to hold an analyst/industry conference call »

Biotechnology Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

OPRX

OptimizeRx

$9.09

0.29 (3.30%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
OptimizeRx management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

SHOO

Steven Madden

$42.85

0.55 (1.30%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
Steven Madden management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ARQL

ArQule

$9.67

0.15 (1.58%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
ArQule to hold an investor conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
JPMorgan integrated oils analyst to hold an analyst/industry conference call »

Integrated Oils &…

ARQL

ArQule

$9.67

0.15 (1.58%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Conference/Events
ArQule »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

RC

Ready Capital

$15.61

0.09 (0.58%)

, CCMP

Cabot Microelectronics

$128.59

1 (0.78%)

04:55
12/09/19
12/09
04:55
12/09/19
04:55
Hot Stocks
Breaking Hot Stocks news story on Ready Capital, Cabot Microelectronics »

Ready Capital to repalce…

RC

Ready Capital

$15.61

0.09 (0.58%)

CCMP

Cabot Microelectronics

$128.59

1 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
12/09/19
12/09
04:55
12/09/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.